Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Petros Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2024 was -$2.63M. For fiscal 2024 it was -$2.63M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$2.63M | – |
| FY2020 | Dec 31, 2020 | -$15.31M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $959.96K | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.74M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.38M | – |
See a number that looks wrong?